Gastroenterology Research and Practice / 2017 / Article / Tab 3

Research Article

Factors Related to Significant Improvement of Estimated Glomerular Filtration Rates in Chronic Hepatitis B Patients Receiving Telbivudine Therapy

Table 3

Table indicating the altered CKD statuses of eGFR (CKD-EPI) changes at month 12 and month 24 according to the baseline eGFR (CKD-EPI) levels.

eGFR (mL/min/1.73 m2)12 months, n (%)Total value
<6060–89≥90

Baseline n (%)<605 (38)8 (62)0 (0)13 (100)0.057
60–891 (2)46 (72)17 (26)64 (100)
≥900 (0)14 (27)38 (73)52 (100)
Total6 (5)68 (52)55 (43)129 (100)

eGFR (mL/min/1.73 m2)24 months, n (%)Total value
<6060–89≥90

Baseline n (%)<602 (15)11 (85)0 (0)13 (100)0.006
60–891 (2)42 (65)21 (33)64 (100)
≥900 (0)13 (25)39 (75)52 (100)
Total3 (2)66 (51)60 (47)129 (100)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.